本页面由Tiger Trade Technology Pte. Ltd.提供服务

Applied Therapeutics Inc.

0.1030
0.0000
成交量:- -
成交额:28.22万
市值:1,486.30万
市盈率:-0.83
高:0.1030
开:0.1030
低:0.1030
收:0.1030
52周最高:1.50
52周最低:0.0900
股本:1.44亿
流通股本:1.20亿
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.1236
每股收益(LYR):-0.7570
净资产收益率:-680.47%
总资产收益率:-88.35%
市净率:-26.49
市盈率(LYR):-0.14

数据加载中...

2025/04/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/04/15

重要事件披露

Form 8-K - Current report
2025/02/10

重要事件披露

Form 8-K - Current report
2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/11

重要事件披露

Form 8-K - Current report
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/27

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/08/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/06/06

重要事件披露

Form 8-K - Current report